Iwatani Balance Sheet Health
Financial Health criteria checks 5/6
Iwatani has a total shareholder equity of ¥382.9B and total debt of ¥253.8B, which brings its debt-to-equity ratio to 66.3%. Its total assets and total liabilities are ¥833.8B and ¥450.9B respectively. Iwatani's EBIT is ¥50.5B making its interest coverage ratio -1366. It has cash and short-term investments of ¥30.3B.
Key information
66.3%
Debt to equity ratio
JP¥253.82b
Debt
| Interest coverage ratio | -1366x |
| Cash | JP¥30.34b |
| Equity | JP¥382.88b |
| Total liabilities | JP¥450.90b |
| Total assets | JP¥833.78b |
Recent financial health updates
These 4 Measures Indicate That Iwatani (TSE:8088) Is Using Debt Reasonably Well
Oct 15
These 4 Measures Indicate That Iwatani (TSE:8088) Is Using Debt Reasonably Well
Jun 10Recent updates
These 4 Measures Indicate That Iwatani (TSE:8088) Is Using Debt Reasonably Well
Oct 15Iwatani (TSE:8088) Has More To Do To Multiply In Value Going Forward
Sep 13Is Now The Time To Put Iwatani (TSE:8088) On Your Watchlist?
Aug 29Lacklustre Performance Is Driving Iwatani Corporation's (TSE:8088) 29% Price Drop
Aug 06These 4 Measures Indicate That Iwatani (TSE:8088) Is Using Debt Reasonably Well
Jun 10Is Now The Time To Put Iwatani (TSE:8088) On Your Watchlist?
May 28Iwatani (TSE:8088) Has Some Way To Go To Become A Multi-Bagger
May 14Iwatani Corporation's (TSE:8088) Subdued P/E Might Signal An Opportunity
Mar 05Financial Position Analysis
Short Term Liabilities: 8088's short term assets (¥296.6B) exceed its short term liabilities (¥295.9B).
Long Term Liabilities: 8088's short term assets (¥296.6B) exceed its long term liabilities (¥155.0B).
Debt to Equity History and Analysis
Debt Level: 8088's net debt to equity ratio (58.4%) is considered high.
Reducing Debt: 8088's debt to equity ratio has reduced from 70.3% to 66.3% over the past 5 years.
Debt Coverage: 8088's debt is well covered by operating cash flow (21.6%).
Interest Coverage: 8088 earns more interest than it pays, so coverage of interest payments is not a concern.